Respiratory diseases in the era of Covid‑19: Pearls and pitfalls
- Maria Bolaki
- Eliza Tsitoura
- Demetrios A. Spandidos
- Emmanouil K. Symvoulakis
- Katerina M. Antoniou
Affiliations: Department of Respiratory Medicine, Laboratory of Molecular and Clinical Pneumonology, Faculty of Medicine, University of Crete, 71003 Heraklion, Greece, Laboratory of Clinical Virology, Medical School, University of Crete, 71003 Heraklion, Greece, Clinic of Social and Family Medicine, Faculty of Medicine, University of Crete, 71003 Heraklion, Greece
- Published online on: May 20, 2020 https://doi.org/10.3892/etm.2020.8776
Copyright: © Bolaki
et al. This is an open access article distributed under the
terms of Creative
Commons Attribution License.
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Coronavirus disease 2019, a respiratory tract infection that has evolved into a pandemic, is expected to affect patients with underlying respiratory disease in a greater number and greater severity than patients with other underlying disorders. Whether this is true is an interesting question. However, the challenge both for the doctors and patients is to keep the respiratory disease in remission and prevent any exacerbations. Proper recommendations have been proposed for a wide range of respiratory disorders including chronic obstructive pulmonary disease (COPD), asthma and interstitial lung diseases, regarding the continuation or not of the treatment during this period and ways to maintain stability.